What this study is
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
What's being tested
- Teleo
Intervention · OTHER
Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
- Standard Videoconferencing
Intervention · OTHER
Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.
Study details
- Sponsor
- Stanford University
- Conditions
- Anxiety · Mood Disorders
- Enrolling
- 156 people
- Starts
- 2026-06-24
- Est. completion
- 2027-09-15
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 5 Years – 14 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Diagnosed with a mood and/or anxiety disorder
- Have proficiency to participate in psychotherapy in English
- Scheduled to begin therapy at one of the study sites
- RCADS score > 65
You can't join if
- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openOhana Center for Child and Adolescent Behavioral Health
Monterey, California, United States
Not yet recruitingStanford University
Stanford, California, United States
- David S Hong, MD · Contact650-724-2939dshong@stanford.edu
Recruiting
Study team
Sponsor
Stanford University
Study ID 80119
Principal investigator
David S Hong, MD
Stanford University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.